The meniscus repair systems market involves medical devices and surgical tools used for repairing meniscus tears in the knees. Meniscus is a c-shaped piece of cartilage present between the thigh and shin bone to act as a shock absorber and provide stability to the knees. However, frequent kneeling, squatting, and sports injuries often lead to tears in the meniscus, causing pain and impaired knee mobility. Meniscus repair systems offer solutions through arthroscopic repairs using suture anchors, suction instruments, arthroscopic knives and shavers to sew back the torn cartilage. The Global meniscus repair systems market is estimated to be valued at US$ 989.23 billion in 2024 and is expected to exhibit a CAGR of 9.4% over the forecast period 2024 to 2031.

Key Takeaways

Key players operating in the meniscus repair systems market are Pfizer Inc., Sanofi SA, Dr. Reddy€TMs Laboratories, Aspen Holdings, Abbott Laboratories, Leo Pharma AS, Alexion Pharmaceuticals Inc., Bayer AG, Johnson & Johnson, Bristol-Myers Squibb Company, Daiichi Sankyo Company, and Boehringer Ingelheim Pharmaceuticals Inc., among others. The rising incidences of sports injuries and road accidents have increased the demand for Meniscus Repair Systems Market surgeries globally. Furthermore, manufacturers are increasingly focusing on developing all-inside repair systems and bioabsorbable implants to repair complex tears, driving the adoption of innovative treatment options.

The growing prevalence of knee injuries due to accidents and sports is a major factor contributing to the rising demand. Statistics show nearly 250,000 meniscus surgeries are performed annually in the US alone. Additionally, the increasing participation in sports and athletic activities has enhanced the risk of damage to ligaments and joints, including meniscus tears. This has accelerated the need for effective repair systems such as suture anchors, implants, and instruments for performing arthroscopic procedures.

Get more insights on Meniscus Repair Systems Market